Monthly Recap: China Pharmaceutical Regulatory Updates | March 2021

by Grace Wang Apr 08, 2021

In Mar. 2021, the Center of Drug Evaluation (CDE) under the China National Medical Products Administration (NMPA) released a total of seven announcements involving technical requirements for drug research & evaluation and reference listed drugs. Following are the keynotes summarized by the ChemLinked BaiPharm team. 

Grace Wang
ChemLinked Regulatory Analyst
+ FOLLOW
Copyright: unless otherwise stated all contents of this website are ©2021 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com